Covered recipient · General Payments record
KARA LINDSAY
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2021–2024
$3,784.74
- Reported across 181 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $306.68 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $131.29 | 4 |
| PFIZER INC. | $55.84 | 3 |
| Amgen Inc. | $50.72 | 3 |
| ABBVIE INC. | $49.18 | 2 |
| DEXCOM, INC. | $19.65 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.26 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107541457 | CMS |
| ABBVIE INC. | $23.92 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107541459 | CMS |
| Amgen Inc. | $20.13 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117612099 | CMS |
| Amgen Inc. | $15.51 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117612101 | CMS |
| Amgen Inc. | $15.08 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117612103 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.07 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1123312050 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.96 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1123304972 | CMS |
| AstraZeneca Pharmaceuticals LP | $95.21 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1123304428 | CMS |
| AstraZeneca Pharmaceuticals LP | $8.05 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1123303286 | CMS |
| Dexcom, Inc. | $19.65 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153369363 | CMS |
| PFIZER INC. | $19.80 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131009833 | CMS |
| PFIZER INC. | $17.72 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131354356 | CMS |
| PFIZER INC. | $18.32 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131785832 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.